ARTICLE | Emerging Company Profile
On-Q-ity: Gently capturing CTCs
On-Q-ity's microfluidic chip captures,characterizes circulating tumor cells
April 18, 2011 7:00 AM UTC
Current technologies can count circulating tumor cells but are unable to characterize them and have low sensitivities and specificities. On-Q-ity Inc. thinks its dual-capture technology for CTCs will improve sensitivity and specificity, as well as provide biological and genetic information about the tumors that will ultimately improve the way cancer is treated.
CTCs are rare cells that break off from advanced solid tumors and flow in the bloodstream. These cells will ultimately be the "absolute game changer" for personalized medicine in cancer, CEO Mara Aspinall told BioCentury...